Clinical Trials

Colorectal Mestatic

• AVF3430n, "A Randomized, Open-Label Trail Comparing Two AvastinT (Bevacizumab) - Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer."
  • Metastatic or locally advanced and unresectable colorectal cancer.
  • No prior treatment with Avastin
  • No brain mets
  • If patient received prior chemo/radiation must be greater then 12 months out
  • We have no patients enrolled in this study.